tirzepatide weight loss non-responder cardiometabolic benefits
Experts Warn Prescription Weight Loss Hidden Cardio Risks?
Experts Warn Prescription Weight Loss Hidden Cardio Risks? In 2024, a meta-analysis of 12 trials found that 68% of tirzepatide recipients showed cardiometabolic improvement even without reaching a 10% weight loss threshold. While these drugs lower blood sugar and appetite, the heart benefits vary by individual response. I have seen